465 related articles for article (PubMed ID: 26937623)
41. The rectal mucosal but not fecal microbiota detects subclinical ulcerative colitis.
Lin YF; Sung CM; Ke HM; Kuo CJ; Liu WA; Tsai WS; Lin CY; Cheng HT; Lu MJ; Tsai IJ; Hsieh SY
Gut Microbes; 2021; 13(1):1-10. PubMed ID: 33525983
[TBL] [Abstract][Full Text] [Related]
42. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.
Liguori G; Lamas B; Richard ML; Brandi G; da Costa G; Hoffmann TW; Di Simone MP; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
J Crohns Colitis; 2016 Mar; 10(3):296-305. PubMed ID: 26574491
[TBL] [Abstract][Full Text] [Related]
43. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
44. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
45. Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease.
Schippa S; Conte MP; Borrelli O; Iebba V; Aleandri M; Seganti L; Longhi C; Chiarini F; Osborn J; Cucchiara S
Inflamm Bowel Dis; 2009 May; 15(5):661-72. PubMed ID: 19067417
[TBL] [Abstract][Full Text] [Related]
46. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
Imai T; Inoue R; Kawada Y; Morita Y; Inatomi O; Nishida A; Bamba S; Kawahara M; Andoh A
J Gastroenterol; 2019 Feb; 54(2):149-159. PubMed ID: 30478724
[TBL] [Abstract][Full Text] [Related]
47. Serological and DNA-based evaluation of Chlamydia pneumoniae infection in inflammatory bowel disease.
Müller S; Arni S; Varga L; Balsiger B; Hersberger M; Maly F; Seibold F
Eur J Gastroenterol Hepatol; 2006 Aug; 18(8):889-94. PubMed ID: 16825908
[TBL] [Abstract][Full Text] [Related]
48. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
Zhang W; Teng G; Wu T; Tian Y; Wang H
Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
[TBL] [Abstract][Full Text] [Related]
49. Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease.
Iboshi Y; Nakamura K; Ihara E; Iwasa T; Akiho H; Harada N; Nakamuta M; Takayanagi R
Inflamm Bowel Dis; 2014 Jun; 20(6):967-77. PubMed ID: 24739631
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
51. Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery.
Mondot S; Lepage P; Seksik P; Allez M; Tréton X; Bouhnik Y; Colombel JF; Leclerc M; Pochart P; Doré J; Marteau P;
Gut; 2016 Jun; 65(6):954-62. PubMed ID: 26628508
[TBL] [Abstract][Full Text] [Related]
52. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
[TBL] [Abstract][Full Text] [Related]
53. Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.
Zhang YL; Cai LT; Qi JY; Lin YZ; Dai YC; Jiao N; Chen YL; Zheng L; Wang BB; Zhu LX; Tang ZP; Zhu RX
World J Gastroenterol; 2019 Jul; 25(25):3242-3255. PubMed ID: 31333315
[TBL] [Abstract][Full Text] [Related]
54. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
55. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Machiels K; Joossens M; Sabino J; De Preter V; Arijs I; Eeckhaut V; Ballet V; Claes K; Van Immerseel F; Verbeke K; Ferrante M; Verhaegen J; Rutgeerts P; Vermeire S
Gut; 2014 Aug; 63(8):1275-83. PubMed ID: 24021287
[TBL] [Abstract][Full Text] [Related]
56. Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.
Alipour M; Zaidi D; Valcheva R; Jovel J; Martínez I; Sergi C; Walter J; Mason AL; Wong GK; Dieleman LA; Carroll MW; Huynh HQ; Wine E
J Crohns Colitis; 2016 Apr; 10(4):462-71. PubMed ID: 26660940
[TBL] [Abstract][Full Text] [Related]
57. Enteric Virome and Bacterial Microbiota in Children With Ulcerative Colitis and Crohn Disease.
Fernandes MA; Verstraete SG; Phan TG; Deng X; Stekol E; LaMere B; Lynch SV; Heyman MB; Delwart E
J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):30-36. PubMed ID: 30169455
[TBL] [Abstract][Full Text] [Related]
58. Gut microbiota analyses of inflammatory bowel diseases from a representative Saudi population.
Alsulaiman RM; Al-Quorain AA; Al-Muhanna FA; Piotrowski S; Kurdi EA; Vatte C; Alquorain AA; Alfaraj NH; Alrezuk AM; Robinson F; Dowdell AK; Alamri TA; Hamilton L; Lad H; Gao H; Gandla D; Keating BJ; Meng R; Piening B; Al-Ali AK
BMC Gastroenterol; 2023 Jul; 23(1):258. PubMed ID: 37507685
[TBL] [Abstract][Full Text] [Related]
59. Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis.
Vester-Andersen MK; Mirsepasi-Lauridsen HC; Prosberg MV; Mortensen CO; Träger C; Skovsen K; Thorkilgaard T; Nøjgaard C; Vind I; Krogfelt KA; Sørensen N; Bendtsen F; Petersen AM
Sci Rep; 2019 Sep; 9(1):13473. PubMed ID: 31530835
[TBL] [Abstract][Full Text] [Related]
60. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis.
Andoh A; Imaeda H; Aomatsu T; Inatomi O; Bamba S; Sasaki M; Saito Y; Tsujikawa T; Fujiyama Y
J Gastroenterol; 2011 Apr; 46(4):479-86. PubMed ID: 21253779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
